These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

852 related items for PubMed ID: 23625945

  • 21. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 22. Incremental cost-effectiveness of guideline-directed medical therapies for heart failure.
    Banka G, Heidenreich PA, Fonarow GC.
    J Am Coll Cardiol; 2013 Apr 02; 61(13):1440-6. PubMed ID: 23433562
    [Abstract] [Full Text] [Related]

  • 23. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
    McNamara DM, Holubkov R, Postava L, Janosko K, MacGowan GA, Mathier M, Murali S, Feldman AM, London B.
    J Am Coll Cardiol; 2004 Nov 16; 44(10):2019-26. PubMed ID: 15542286
    [Abstract] [Full Text] [Related]

  • 24. Role of a selective aldosterone blocker in mice with chronic heart failure.
    Wang D, Liu YH, Yang XP, Rhaleb NE, Xu J, Peterson E, Rudolph AE, Carretero OA.
    J Card Fail; 2004 Feb 16; 10(1):67-73. PubMed ID: 14966777
    [Abstract] [Full Text] [Related]

  • 25. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
    Cohn JN, Tognoni G, Valsartan Heart Failure Trial Investigators.
    N Engl J Med; 2001 Dec 06; 345(23):1667-75. PubMed ID: 11759645
    [Abstract] [Full Text] [Related]

  • 26. [Therapy of heart failure after myocardial infarction. With eplerenone a new course].
    MMW Fortschr Med; 2004 Oct 21; 146(43):58-9. PubMed ID: 15559524
    [No Abstract] [Full Text] [Related]

  • 27. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.
    Güder G, Störk S, Gelbrich G, Brenner S, Deubner N, Morbach C, Wallenborn J, Berliner D, Ertl G, Angermann CE.
    Eur J Heart Fail; 2015 Apr 21; 17(4):442-52. PubMed ID: 25727879
    [Abstract] [Full Text] [Related]

  • 28. Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trial.
    Girerd N, Collier T, Pocock S, Krum H, McMurray JJ, Swedberg K, Van Veldhuisen DJ, Vincent J, Pitt B, Zannad F.
    Eur Heart J; 2015 Sep 07; 36(34):2310-7. PubMed ID: 26093641
    [Abstract] [Full Text] [Related]

  • 29. Eplerenone: a review of its use in patients with chronic systolic heart failure and mild symptoms.
    Dhillon S.
    Drugs; 2013 Sep 07; 73(13):1451-62. PubMed ID: 23881669
    [Abstract] [Full Text] [Related]

  • 30. Eplerenone: a selective aldosterone receptor antagonist for patients with heart failure.
    Barnes BJ, Howard PA.
    Ann Pharmacother; 2005 Jan 07; 39(1):68-76. PubMed ID: 15590870
    [Abstract] [Full Text] [Related]

  • 31. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.
    Moore TD, Nawarskas JJ, Anderson JR.
    Heart Dis; 2003 Jan 07; 5(5):354-63. PubMed ID: 14503934
    [Abstract] [Full Text] [Related]

  • 32. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
    Shah R, Wang Y, Foody JM.
    Am J Cardiol; 2008 Jan 15; 101(2):217-22. PubMed ID: 18178410
    [Abstract] [Full Text] [Related]

  • 33. Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS-HF study.
    Chin KL, Collier TJ, Pitt B, McMurray JJ, Swedberg K, van Veldhuisen DJ, Pocock SJ, Vincent J, Turgonyi E, Zannad F, Krum H, EMPHASIS-HF Study Investigators.
    Eur J Heart Fail; 2016 Sep 15; 18(9):1175-81. PubMed ID: 26833642
    [Abstract] [Full Text] [Related]

  • 34. Adherence to aldosterone-blocking agents in patients with heart failure.
    Margolis J, Gerber RA, Roberts C, Gheorghiade M.
    Am J Ther; 2010 Sep 15; 17(5):446-54. PubMed ID: 20844344
    [Abstract] [Full Text] [Related]

  • 35. Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy.
    Rossignol P, Ménard J, Fay R, Gustafsson F, Pitt B, Zannad F.
    J Am Coll Cardiol; 2011 Nov 01; 58(19):1958-66. PubMed ID: 22032706
    [Abstract] [Full Text] [Related]

  • 36. Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes.
    Epstein M, Williams GH, Weinberger M, Lewin A, Krause S, Mukherjee R, Patni R, Beckerman B.
    Clin J Am Soc Nephrol; 2006 Sep 01; 1(5):940-51. PubMed ID: 17699311
    [Abstract] [Full Text] [Related]

  • 37. Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure (EMPHASIS-HF).
    Cannon JA, Collier TJ, Shen L, Swedberg K, Krum H, Van Veldhuisen DJ, Vincent J, Pocock SJ, Pitt B, Zannad F, McMurray JJ.
    Eur J Heart Fail; 2015 Jul 01; 17(7):707-16. PubMed ID: 26139584
    [Abstract] [Full Text] [Related]

  • 38. Combination Therapy of Renin Angiotensin System Inhibitors and β-Blockers in Patients with Heart Failure.
    Nochioka K, Sakata Y, Shimokawa H.
    Adv Exp Med Biol; 2018 Jul 01; 1067():17-30. PubMed ID: 29542073
    [Abstract] [Full Text] [Related]

  • 39. Eplerenone in patients with systolic heart failure and mild symptoms.
    Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B, EMPHASIS-HF Study Group.
    N Engl J Med; 2011 Jan 06; 364(1):11-21. PubMed ID: 21073363
    [Abstract] [Full Text] [Related]

  • 40. Eplerenone in chronic heart failure with depressed systolic function.
    Volterrani M, Iellamo F.
    Int J Cardiol; 2015 Dec 01; 200():12-4. PubMed ID: 26044084
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 43.